Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2014 | 08-2014 | 06-2014 | 05-2014 | 03-2014 | |
| Sales | 7 | 7 | 56 | 56 | 201 |
| Cost of Goods | 5 | 5 | 20 | 20 | N/A |
| Gross Profit | 3 | 3 | 20 | 20 | 201 |
| Operating Expenses | 3,185 | 3,180 | 2,740 | 2,720 | 0 |
| Operating Income | -3,178 | -3,178 | -2,684 | -2,684 | 201 |
| Interest Expense | 0 | 0 | 1 | 1 | 0 |
| Other Income | -242 | -242 | 3,915 | 3,915 | 0 |
| Pre-tax Income | -3,420 | -3,420 | 1,230 | 1,230 | 201 |
| Net Income Continuous | -3,305 | -3,305 | 1,356 | 1,356 | -2,553 |
| Net Income | $-3,305 | $-3,305 | $1,356 | $1,356 | $-2,553 |
| EPS Basic Total Ops | -14.40 | -0.30 | 4.80 | 0.10 | -9.60 |
| EPS Basic Continuous Ops | -14.93 | -0.31 | 6.15 | 0.13 | -11.45 |
| EPS Diluted Total Ops | -14.40 | -0.30 | 4.80 | 0.10 | -9.60 |
| EPS Diluted Continuous Ops | -14.93 | -0.31 | 6.09 | 0.13 | -11.45 |
| EBITDA(a) | $-2,109 | $-2,109 | $-2,683 | $-2,683 | $611 |